Display options
Cite
Vallières A, Ceklic T, Bastien CH, et al. A preliminary evaluation of the physiological mechanisms of action for sleep restriction therapy. Sleep Disord. 2013;2013:726372doi: 10.1155/2013/726372.
Vallières, A., Ceklic, T., Bastien, C. H., & Espie, C. A. (2013). A preliminary evaluation of the physiological mechanisms of action for sleep restriction therapy. Sleep disorders, 2013726372. https://doi.org/10.1155/2013/726372
Vallières, Annie, et al. "A preliminary evaluation of the physiological mechanisms of action for sleep restriction therapy." Sleep disorders vol. 2013 (2013): 726372. doi: https://doi.org/10.1155/2013/726372
Vallières A, Ceklic T, Bastien CH, Espie CA. A preliminary evaluation of the physiological mechanisms of action for sleep restriction therapy. Sleep Disord. 2013;2013:726372. doi: 10.1155/2013/726372. Epub 2013 Nov 20. PMID: 24349793; PMCID: PMC3856159.
Copy Download .nbib Format: NLM
Share it on

Sleep Disord. 2013;2013:726372. doi: 10.1155/2013/726372. Epub 2013 Nov 20.

A preliminary evaluation of the physiological mechanisms of action for sleep restriction therapy.

Sleep disorders

Annie Vallières, Tijana Ceklic, Célyne H Bastien, Colin A Espie

Affiliations

  1. École de psychologie, Université Laval, Québec, QC, Canada G1V A06 ; Centre d'étude des troubles du sommeil, Centre de recherche de l'institut universitaire en santé mentale de Québec, Québec, QC, Canada G1J 2G3 ; Centre de recherche du centre hospitalier universitaire en santé mentale du Québec, Québec, QC, Canada G1V 4G2.
  2. École de psychologie, Université Laval, Québec, QC, Canada G1V A06 ; Centre d'étude des troubles du sommeil, Centre de recherche de l'institut universitaire en santé mentale de Québec, Québec, QC, Canada G1J 2G3.
  3. Nuffield Department of Clinical Neurosciences, Sleep & Circadian Neuroscience Institute, University of Oxford, Oxford OX3 9DU, UK.

PMID: 24349793 PMCID: PMC3856159 DOI: 10.1155/2013/726372

Abstract

Our objective was to investigate the physiological mechanisms involved in the sleep restriction treatment of insomnia. A multiple baseline across subjects design was used. Sleep of five participants suffering from insomnia was assessed throughout the experimentation by sleep diaries and actigraphy. Ten nights of polysomnography were conducted over five occasions. The first two-night assessment served to screen for sleep disorders and to establish a baseline for dependent measures. Three assessments were undertaken across the treatment interval, with the fifth and last one coming at follow-up. Daily cortisol assays were obtained. Sleep restriction therapy was applied in-lab for the first two nights of treatment and was subsequently supervised weekly. Interrupted time series analyses were computed on sleep diary data and showed a significantly decreased wake time, increased sleep efficiency, and decreased total sleep time. Sleepiness at night seems positively related to sleep variables, polysomnography data suggest objective changes mainly for stage 2, and power spectral analysis shows a decrease in beta-1 and -2 powers for the second night of treatment. Cortisol levels seem to be lower during treatment. These preliminary results confirm part of the proposed physiological mechanisms and suggest that sleep restriction contributes to a rapid decrease in hyperarousal insomnia.

References

  1. J Sleep Res. 2013 Jun;22(3):266-72 - PubMed
  2. Int J Psychophysiol. 2013 Aug;89(2):181-94 - PubMed
  3. Pharmacopsychiatry. 2012 Jul;45(5):167-76 - PubMed
  4. Front Neurol. 2012 Mar 30;3:47 - PubMed
  5. Sleep. 2006 Nov;29(11):1415-9 - PubMed
  6. Electroencephalogr Clin Neurophysiol. 1998 Aug;107(2):122-32 - PubMed
  7. J Sleep Res. 2001 Sep;10(3):229-35 - PubMed
  8. Am J Psychiatry. 1994 Aug;151(8):1172-80 - PubMed
  9. Psychol Aging. 1988 Sep;3(3):258-63 - PubMed
  10. Sleep. 1987 Feb;10(1):45-56 - PubMed
  11. Sleep. 2014 Feb 01;37(2):229-37 - PubMed
  12. Psychoneuroendocrinology. 2004 Oct;29(9):1184-91 - PubMed
  13. J Sleep Res. 2004 Dec;13(4):385-93 - PubMed
  14. JAMA. 2009 May 20;301(19):2005-15 - PubMed
  15. Sleep. 2010 May;33(5):669-77 - PubMed
  16. Sleep Med Rev. 2006 Aug;10(4):247-54 - PubMed
  17. Sleep Med. 2011 Sep;12(8):735-47 - PubMed
  18. Sleep. 2006 Nov;29(11):1398-414 - PubMed
  19. Am J Psychiatry. 2002 Jan;159(1):5-11 - PubMed
  20. Sleep. 2011 May 01;34(5):601-8 - PubMed
  21. Appl Ergon. 2008 Sep;39(5):653-62 - PubMed
  22. Clin Psychol Rev. 2005 Jul;25(5):539-58 - PubMed
  23. J Sleep Res. 2012 Oct;21(5):527-34 - PubMed
  24. Sleep Med. 2001 Jul;2(4):297-307 - PubMed
  25. J Consult Clin Psychol. 1995 Feb;63(1):79-89 - PubMed
  26. Health Psychol. 2006 Jan;25(1):3-14 - PubMed
  27. Psychiatry Clin Neurosci. 2001 Jun;55(3):305-10 - PubMed
  28. J Sleep Res. 2008 Jun;17(2):180-90 - PubMed
  29. J Clin Endocrinol Metab. 2001 Aug;86(8):3787-94 - PubMed
  30. J Sleep Res. 1996 Sep;5(3):155-64 - PubMed

Publication Types